Elanco Animal Health Incorporated (BMV:ELAN)

Market Cap	212.01B +75.6%
Revenue (ttm)	84.21B +3.1%
Net Income	660.32M -82.4%
EPS	1.30 -82.8%
Shares Out	n/a
PE Ratio	321.07
Forward PE	25.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	533
Average Volume	539
Open	399.50
Previous Close	262.00
Day's Range	392.00 - 399.50
52-Week Range	246.50 - 399.50
Beta	n/a
RSI	n/a
Earnings Date	Feb 24, 2026

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 9,450
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ELAN

Financial Performance

Financial numbers in USD